Authors: Aeschlimann, JR Hershberger, E Rybak, MJ

Citation: Jr. Aeschlimann et al., Activities of trovafloxacin and ampicillin-sulbactam alone or in combination versus three strains of vancomycin-intermediate Staphylococcus aureus inan in vitro pharmacodynamic infection model, ANTIM AG CH, 44(5), 2000, pp. 1153-1158

Authors: Aeschlimann, JR Allen, GP Hershberger, E Rybak, MJ

Citation: Jr. Aeschlimann et al., Activities of LY333328 and vancomycin administered alone or in combinationwith gentamicin against three strains of vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model, ANTIM AG CH, 44(11), 2000, pp. 2991-2998

Authors: Aeschlimann, JR Kaatz, GW Rybak, MJ

Citation: Jr. Aeschlimann et al., The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model, J ANTIMICRO, 44(3), 1999, pp. 343-349

Authors: Aeschlimann, JR Hershberger, E Rybak, MJ

Citation: Jr. Aeschlimann et al., Analysis of vancomycin population susceptibility profiles, killing activity, and postantibiotic effect against vancomycin-intermediate Staphylococcusaureus, ANTIM AG CH, 43(8), 1999, pp. 1914-1918

Authors: Hershberger, E Aeschlimann, JR Moldovan, T Rybak, MJ

Citation: E. Hershberger et al., Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by time-kill curve methods, ANTIM AG CH, 43(3), 1999, pp. 717-721

Authors: Aeschlimann, JR Dresser, LD Kaatz, GW Rybak, MJ

Citation: Jr. Aeschlimann et al., Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus, ANTIM AG CH, 43(2), 1999, pp. 335-340